News & Updates
Filter by Specialty:
SABR yields better survival, tumour control in oligometastatic HCC
Treatment with stereotactic ablative radiotherapy (SABR) results in excellent local tumour control and improves survival among patients with oligometastatic hepatocellular carcinoma (HCC), with no serious adverse effects, reports a study.
SABR yields better survival, tumour control in oligometastatic HCC
05 Jul 2024
Liver stiffness predicts decompensation, mortality in ALD patients
Clinicians may use liver stiffness measurement (LSM) by transient elastography (TE) to accurately predict decompensation and all-cause mortality in patients with compensated alcohol-related liver disease (ALD), suggests a study.
Liver stiffness predicts decompensation, mortality in ALD patients
04 Jul 2024
Exercise, Mediterranean diet remain key against MASLD
A 12-week lifestyle intervention comprising a moderate-intensity physical activity (PA) programme and a hypocaloric Mediterranean diet (MD) promoted fat removal and liver fibrosis improvement in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD), findings from the EHmet-DIA study suggest.
Exercise, Mediterranean diet remain key against MASLD
21 Jun 2024
Obeticholic acid reduces progression to cirrhosis in patients with MASH-related fibrosis
Treatment with obeticholic acid (OCA) improves clinical outcome in patients with precirrhotic fibrosis due to metabolic dysfunction-associated steatohepatitis (MASH), with a reduction in histological progression to cirrhosis seen in those receiving the 25-mg dose, as seen in the final results of the REGENERATE study.